Image Place holder

Christine Laronga, MD, FACS

Specialty: Surgery
Program: Breast Oncology


Cancer Focus: Breast Cancer, Ductal Carcinoma In Situ, Inflammatory Breast Cancer, Invasive Ductal Carcinoma, Triple Negative Breast Cancer

Dr. Christine Laronga is a surgical oncologist specializing in breast cancer in the Comprehensive Breast Program at the Center for Women’s Oncology at Moffitt Cancer Center in Tampa, Florida. Dr. Laronga enjoys making a difference in women’s lives through her clinical practice and research.  She treats women with all levels of breast disease, from benign cysts to metastatic breast cancer.Dr. Laronga is a principal investigator for several ground-breaking procedures, including nipple and areola skin-sparing efforts after mastectomy and liposuction for arm lymphedema resulting from breast cancer treatment.  She also conducts basic research in proteomics, the study of protein markers in tissue and blood.At the national level, Dr. Laronga is a member of the National Comprehensive Cancer Network breast risk reduction panel that reviews guidelines for treating women at high risk for breast cancer.  She is treasurer for the Association of Women Surgeons (an international society). She is also a member of the American Cancer Society Clinical Cancer and Epidemiology study section evaluating research grant applications.  In addition, she is a member of the National Consortium of Breast Centers and is the Florida State Chair for the American College of Surgeons’ Commission on Cancer.Dr. Laronga is extensively published in professional journals, has written several book chapters, speaks at numerous national and international scientific meetings, and is on the editorial board for several medical journals.  

Education & Training


  • University of Texas- MD Anderson Cancer Center - Surgical Oncology


  • University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School Piscataway -
  • University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School Piscataway - General Surgery

Medical School:

  • University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School Piscataway - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.


  • Soliman H, Hogue D, Han H, Mooney B, Costa R, Lee MC, Niell B, Williams A, Chau A, Falcon S, Soyano A, Armaghani A, Khakpour N, Weinfurtner RJ, Hoover S, Kiluk J, Laronga C, Rosa M, Khong H, Czerniecki B. Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial. Nat Med. 2023 Mar. Pubmedid: 36932246.
  • Laronga C, Gantt NL. Time to Increase Awareness of Breast Milk Pumping Among Postpartum Trainees and In-Practice Surgeons. World J Surg. 2023 Jun. Pubmedid: 37268783.
  • Soliman H, Hogue D, Han H, Mooney B, Costa R, Lee MC, Niell B, Williams A, Chau A, Falcon S, Soyano A, Armaghani A, Khakpour N, Weinfurtner RJ, Hoover S, Kiluk J, Laronga C, Rosa M, Khong H, Czerniecki B. Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial. Nat Med. 2023 Feb.29(2):450-457. Pubmedid: 36759673.
  • Liveringhouse CL, Mills MN, Ahmed KA, Washington IR, Lee MC, Khakpour N, Laronga C, Czerniecki B, Soliman H, Weinfurtner RJ, Rosa M, Kim Y, Stringfield O, Abdalah M, Diaz R, Montejo M. Phase 2 Study of Preoperative SABR for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 Feb. Pubmedid: 36796498.
  • Englander K, Chintapally N, Gallagher J, Elleson K, Sun W, Whiting J, Laronga C, Lee MC. Factors Influencing Lymph Node Positivity in HER2/neu+ Breast Cancer Patients. Curr Oncol. 2023 Feb.30(3):2825-2833. Pubmedid: 36975428. Pmcid: PMC10047436.
  • Sinner HF, Naffouje S, Selfridge JM, Lee MC, Hoover SJ, Laronga C. Surgical Management of the Axilla in Invasive Lobular Carcinoma in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer Database. Curr Oncol. 2022 Oct.29(11):8197-8206. Pubmedid: 36354707. Pmcid: PMC9689286.
  • Naffouje SA, Barker V, Lee MC, Hoover SJ, Laronga C. Surgical Management of Axilla of Triple-Negative Breast Cancer in the Z1071 Era: A Propensity Score-Matched Analysis of the National Cancer Database. Ann Surg Oncol. 2022 May.29(5):2985-2997. Pubmedid: 35006503.
  • Naffouje SA, Barker V, Lee MC, Hoover SJ, Laronga C. ASO Visual Abstract: Surgical Management of the Axilla of Triple-Negative Breast Cancer in the Z1071 Era-A Propensity-Score Matched Analysis of the National Cancer Database. Ann Surg Oncol. 2022 May.29(5):2998-2999. Pubmedid: 35076771.
  • Weinstein B, Le NK, Robertson E, Zimmerman A, Tavares T, Tran T, Laronga C, Panetta NJ. Reverse Lymphatic Mapping and Immediate Microsurgical Lymphatic Reconstruction Reduces Early Risk of Breast Cancer-Related Lymphedema. Plast Reconstr Surg. 2022 May.149(5):1061-1069. Pubmedid: 35255010.
  • Weinfurtner RJ, Abdalah M, Stringfield O, Ataya D, Williams A, Mooney B, Rosa M, Lee MC, Khakpour N, Laronga C, Czerniecki B, Diaz R, Ahmed K, Washington I, Latifi K, Niell B, Montejo M, Raghunand N. Quantitative Changes in Intratumoral Habitats on MRI Correlate With Pathologic Response in Early-stage ER/PR+ HER2− Breast Cancer Treated With Preoperative Stereotactic Ablative Body Radiotherapy. J Breast Imaging. 2022 May.4(3):273-284. Pubmedid: 36686407. Pmcid: PMC9851176.
  • Brajcich BC, Stigall K, Walsh DS, Varghese TK, Barber AE, Kralovich KA, Wescott AB, Pockaj BA, Ko CY, Laronga C. Preoperative Nutritional Optimization of the Oncology Patient: A Scoping Review. J Am Coll Surg. 2022 Mar.234(3):384-394. Pubmedid: 35213503.
  • Soni SE, Le NK, Buller M, Modica AD, Kumar A, Smith PD, Laronga C. Complication Profile of Total Submuscular Versus Prepectoral Tissue Expander Placement: A Retrospective Cohort Study. Ann Plast Surg. 2022 Jun.88(5 Suppl 5):S439-S442. Pubmedid: 35502960.
  • Wells KJ, Drizin JH, Ustjanauskas AE, Vázquez-Otero C, Pan-Weisz TM, Ung D, Carrizosa C, Laronga C, Roetzheim RG, Johnson K, Norton M, Aguilar RC, Quinn GP. The psychosocial needs of underserved breast cancer survivors and perspectives of their clinicians and support providers. Support Care Cancer. 2022 Jan.30(1):105-116. Pubmedid: 34231040. Pmcid: PMC8639634.
  • Weinfurtner RJ, Raghunand N, Stringfield O, Abdalah M, Niell BL, Ataya D, Williams A, Mooney B, Rosa M, Lee MC, Khakpour N, Laronga C, Czerniecki B, Diaz R, Ahmed K, Washington I, Montejo M. MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity. Clin Breast Cancer. 2022 Feb.22(2):e214-e223. Pubmedid: 34384695.
  • Selfridge JM, Sinner HF, Whiting J, Sun W, Mallory MA, Hoover SJ, Kiluk JV, Khakpour N, Czerniecki BJ, Laronga C, Mo Q, Lee MC. Effect of Microporous Polysaccharide Particles in Patients Undergoing Mastectomy. Clin Breast Cancer. 2022 Dec.22(8):e922-e927. Pubmedid: 36055918.
  • Brown L, Naffouje SA, Sam C, Laronga C, Catherine Lee M. Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis. Breast Cancer Res Treat. 2022 Dec.196(3):441-451. Pubmedid: 36207620.
  • Blaschke CRK, Hill EG, Mehta AS, Angel PM, Laronga C, Drake RR. Integrating age, BMI, and serum N-glycans detected by MALDI mass spectrometry to classify suspicious mammogram findings as benign lesions or breast cancer. Sci Rep. 2022 Dec.12(1):20801. Pubmedid: 36460712. Pmcid: PMC9718781.
  • Sun J, Zhong X, Ma J, Sun W, Han HS, Soliman HH, Loftus LS, Costa RLB, Armaghani AJ, Soyano-Muller AE, Czerniecki BJ, Lee MC, Kiluk JV, Khakpour N, Hoover SJ, Laronga C, Khong HT. Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia. Cancer Med. 2021 Nov.10(21):7665-7672. Pubmedid: 34590788. Pmcid: PMC8559460.
  • Valente SA, Tendulkar RD, Cherian S, Shah C, Ross DL, Lottich SC, Laronga C, Broman KK, Donnelly ED, Bethke KP, Shaw C, Lockney NA, Pederson A, Rudolph R, Hasselle M, Kelemen P, Hermanto U, Ashikari A, Kang S, Hoefer RA, McCready D, Fyles A, Escallon J, Rohatgi N, Graves J, Graves G, Willey SC, Tousimis E, Riley L, Deb N, Tu C, Small W, Grobmyer SR. TARGIT-R (Retrospective): 5-Year Follow-Up Evaluation of Intraoperative Radiation Therapy (IORT) for Breast Cancer Performed in North America. Ann Surg Oncol. 2021 May.28(5):2512-2521. Pubmedid: 33433786.
  • Sun J, Henry DA, Carr MJ, Yazdankhahkenary A, Laronga C, Lee MC, Hoover SJ, Sun W, Czerniecki BJ, Khakpour N, Kiluk JV. Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization. Clin Breast Cancer. 2021 Jun.21(3):e189-e193. Pubmedid: 32893094.
  • Le NK, Weinstein B, Serraneau K, Tavares T, Laronga C, Panetta N. The Learning Curve: Trends in the First 100 Immediate Lymphatic Reconstructions Performed at a Single Institution. Ann Plast Surg. 2021 Jun.86(6S Suppl 5):S495-S497. Pubmedid: 34100805.
  • Sun J, Mathias BJ, Sun W, Fulp WJ, Zhou JM, Laronga C, Loftus LS, Lee MC. Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?. Ann Surg Oncol. 2021 Jan.28(1):320-329. Pubmedid: 32613363.
  • Sun J, Mathias BJ, Laronga C, Sun W, Zhou JM, Fulp WJ, Kiluk JV, Lee MC. Impact of Axillary Dissection Among Patients With Sentinel Node-Positive Breast Cancer Undergoing Mastectomy. J Natl Compr Canc Ne. 2021 Jan.19(1):40-47. Pubmedid: 33406495.
  • Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML, Karlan BY, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G, Senter-Jamieson L, Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Ne. 2021 Jan.19(1):77-102. Pubmedid: 33406487.
  • Mathias BJ, Sun J, Sun W, Zhou JM, Fulp WJ, Laronga C, Lee MC, Kiluk JV. Surgeon Bias in the Management of Positive Sentinel Lymph Nodes. Clin Breast Cancer. 2021 Feb.21(1):74-79. Pubmedid: 32917535.
  • Naffouje SA, Sabesan A, Hoover SJ, Lee MC, Laronga C. Surgical Management of the Axilla of HER2+ Breast Cancer in the Z1071 Era: A Propensity-Score-Matched Analysis of the NCDB. Ann Surg Oncol. 2021 Dec.28(13):8777-8788. Pubmedid: 34258723.
  • Naffouje SA, Sabesan A, Hoover SJ, Lee MC, Laronga C. ASO Visual Abstract: Surgical Management of the Axilla of HER2+ Breast Cancer in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer Database. Ann Surg Oncol. 2021 Dec.28(Suppl 3):581-582. Pubmedid: 34363117.
  • Siegel EL, Whiting J, Kim Y, Sun W, Laronga C, Lee MC. Effect of surgical complications on outcomes in breast cancer patients treated with mastectomy and immediate reconstruction. Breast Cancer Res Treat. 2021 Aug.188(3):641-648. Pubmedid: 33939063.
  • Strang LR, Sun J, Sun W, Boulware D, Kiluk JV, Lee MC, Khazai L, Laronga C. Characteristics of Microinvasive Ductal Carcinoma In Situ Versus Noninvasive and Invasive Breast Cancer. J Surg Res. 2020 Oct.254:378-383. Pubmedid: 32535256.
  • Broman KK, Joya L, Sun W, Zhou JM, Fridley B, Javedan K, Diaz R, Laronga C. Utility of Taking Additional Margins When Performing Breast-Conserving Surgery with Intraoperative Radiation Therapy for Early Breast Cancer. World J Surg. 2020 Oct.44(10):3410-3416. Pubmedid: 32696098.
  • Brenin DR, Dietz JR, Baima J, Cheng G, Froman J, Laronga C, Ma A, Manahan MA, Mariano ER, Rojas K, Schroen AT, Tiouririne NA, Wiechmann LS, Rao R. Pain Management in Breast Surgery: Recommendations of a Multidisciplinary Expert Panel-The American Society of Breast Surgeons. Ann Surg Oncol. 2020 Nov.27(12):4588-4602. Pubmedid: 32783121.
  • Hu QL, Dworsky JQ, Beck AC, Gilbert EW, Pockaj BA, Varghese TK, Maggard-Gibbons M, Ko CY, Weigel RJ, Laronga C. Perioperative Pain Management after Ambulatory Abdominal Surgery: An American College of Surgeons Systematic Review. J Am Coll Surg. 2020 Nov.231(5):572-601.e27. Pubmedid: 32805404.
  • Sun J, Chen DT, Li J, Sun W, Yoder SJ, Mesa TE, Wloch M, Roetzheim R, Laronga C, Lee MC. Development of Malignancy-Risk Gene Signature Assay for Predicting Breast Cancer Risk. J Surg Res. 2020 Jan.245:153-162. Pubmedid: 31419640. Pmcid: PMC6900446.
  • Burke EE, Laronga C, Sun W, DeBiase S, Naqvi SMH, Fridley B, Czerniecki BJ, Hoover SJ, Khakpour N, Kiluk JV, Lee MC. Implant-sparing Mastectomy: An Alternative for Women Undergoing Mastectomy With Retropectoral Implants. Clin Breast Cancer. 2020 Feb.20(1):e14-e19. Pubmedid: 31780380. Pmcid: PMC7771331.
  • Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Dwyer MA, Darlow SD. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. J Natl Compr Canc Ne. 2020 Apr.18(4):380-391. Pubmedid: 32259785.
  • Broman K, Sun W, Zhou JM, Fridley B, Diaz R, Laronga C. Outcomes of selective whole breast irradiation following lumpectomy with intraoperative radiation therapy for hormone receptor positive breast cancer. Am J Surg. 2019 Oct.218(4):749-754. Pubmedid: 31345502. Pmcid: PMC7810130.
  • McNamara GPJ, Ali KN, Vyas S, Huynh T, Nyland M, Almanza D, Laronga C, Klapman J, Permuth JB. Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center. Gastrointest Disord (Basel). 2019 Mar.1(1):106-119. Pubmedid: 32601617. Pmcid: PMC7324042.
  • Henry DA, Lee MC, Almanza D, Ahmed KA, Sun W, Boulware DC, Laronga C. Trends in use of bilateral prophylactic mastectomy vs high-risk surveillance in unaffected carriers of inherited breast cancer syndromes in the Inherited Cancer Registry (ICARE). Breast Cancer Res Treat. 2019 Feb.174(1):39-45. Pubmedid: 30474778. Pmcid: PMC7771240.
  • Hornor MA, Duane TM, Ehlers AP, Jensen EH, Brown PS, Pohl D, da Costa PM, Ko CY, Laronga C. American College of Surgeons' Guidelines for the Perioperative Management of Antithrombotic Medication. J Am Coll Surg. 2018 Nov.227(5):521-536.e1. Pubmedid: 30145286.
  • Small W, Thomas TO, Alvarado M, Baum M, Bulsara M, Diaz R, Donnelly E, Feldman S, Grobmyer S, Hoefer R, Joseph D, Kang S, Laronga C, McKee A, Rosen B, Tobias J, Uhl V, Vaidya JS, Wenz F, Holmes D. Commentary on "Accelerated partial breast irradiation consensus statement: Update of an ASTRO Evidence-Based Consensus Statement". Pract Radiat Oncol. 2018 Mar.7(3):e159-e163. Pubmedid: 28363492.
  • Mills MN, Yang GQ, Oliver DE, Liveringhouse CL, Ahmed KA, Orman AG, Laronga C, Hoover SJ, Khakpour N, Costa RLB, Diaz R. Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis. Eur J Cancer. 2018 Jul.98:48-58. Pubmedid: 29870876.
  • Powers B, Pal T, Laronga C. Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine. Surg Oncol Clin N Am. 2018 Jan.27(1):1-22. Pubmedid: 29132555.
  • Loftus LS, Sokol GH, Laronga C. Breast Cancer Survivorship: Patient Characteristics and Plans for High-Quality Care. South Med J. 2017 Oct.110(10):673-677. Pubmedid: 28973710.
  • Mattingly AE, Ma Z, Smith PD, Kiluk JV, Khakpour N, Hoover SJ, Laronga C, Lee MC. Early Postoperative Complications after Oncoplastic Reduction. South Med J. 2017 Oct.110(10):660-666. Pubmedid: 28973708. Pmcid: PMC7771341.
  • Orcutt ST, O'Donoghue C, Smith P, Laronga C. Expanding Eligibility Criteria for Nipple-Sparing Mastectomy. South Med J. 2017 Oct.110(10):654-659. Pubmedid: 28973707.
  • Gangi A, Topham A, Lee MC, Sun W, Laronga C. Genomic Assays in Ductal Carcinoma In Situ: Implications for Management Decisions. South Med J. 2017 Oct.110(10):649-653. Pubmedid: 28973706.
  • Pal T, Brzosowicz J, Valladares A, Wiesner GL, Laronga C. Identification and Management of Gene Carriers Detected Through Multigene Panel Testing. South Med J. 2017 Oct.110(10):643-648. Pubmedid: 28973705.
  • Abbott AM, Valente SA, Loftus L, Tendulkar RD, Greif JM, Bethke KP, Donnelly ED, Lottich C, Ross DL, Friedman NB, Bedi CG, Joh JE, Kelemen P, Hoefer RA, Kang SK, Ruffer J, Police A, Fyles A, Graves GM, Willey SC, Tousimis EA, Small W, Lyons J, Grobmyer S, Laronga C. A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?. Am J Surg. 2017 Oct.214(4):629-633. Pubmedid: 28918848.
  • Ban KA, Minei JP, Laronga C, Harbrecht BG, Jensen EH, Fry DE, Itani KMF, Dellinger EP, Ko CY, Duane TM. Executive Summary of the American College of Surgeons/Surgical Infection Society Surgical Site Infection Guidelines-2016 Update. Surg Infect (Larchmt). 2017 May.18(4):379-382. Pubmedid: 28541808.
  • Mattingly AE, Mooney B, Lin HY, Kiluk JV, Khakpour N, Hoover SJ, Laronga C, Lee MC. Magnetic Resonance Imaging for Axillary Breast Cancer Metastasis in the Neoadjuvant Setting: A Prospective Study. Clin Breast Cancer. 2017 Jun.17(3):180-187. Pubmedid: 27956116.
  • Mellon EA, Orman A, Joya LE, Montejo ME, Laronga C, Hoover SJ, Lee MC, Khakpour N, Kubal PF, Diaz R. Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy. Brachytherapy. 2017 Jul.16(1):174-180. Pubmedid: 27816540.
  • Collins M, O'Donoghue C, Sun W, Zhou JM, Ma Z, Laronga C, Lee MC. Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer. J Surg Res. 2017 Jul.215:55-59. Pubmedid: 28688661.
  • Ban KA, Minei JP, Laronga C, Harbrecht BG, Jensen EH, Fry DE, Itani KM, Dellinger EP, Ko CY, Duane TM. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017 Jan.224(1):59-74. Pubmedid: 27915053.
  • Ustjanauskas AE, Quinn GP, Pan TM, Rivera M, Vázquez-Otero C, Ung D, Roetzheim RG, Laronga C, Johnson K, Norton M, Carrizosa C, Muñoz D, Goldenstein M, Nuhaily S, Wells KJ. Facilitators of Survivorship Care Among Underserved Breast Cancer Survivors: a Qualitative Study. J Cancer Educ. 2017 Dec.32(4):756-763. Pubmedid: 27385123. Pmcid: PMC5219875.
  • Sanfey H, Crandall M, Shaughnessy E, Stein SL, Cochran A, Parangi S, Laronga C. Strategies for Identifying and Closing the Gender Salary Gap in Surgery. J Am Coll Surg. 2017 Aug.225(2):333-338. Pubmedid: 28400299.
  • González SJ, Mooney B, Lin HY, Zhao X, Kiluk JV, Khakpour N, Laronga C, Lee MC. 2-D and 3-D Ultrasound for Tumor Volume Analysis: A Prospective Study. Ultrasound Med Biol. 2017 Apr.43(4):775-781. Pubmedid: 28187928.
  • Valente SA, Tendulkar RD, Cherian S, O'Rourke C, Greif JM, Bailey L, Uhl V, Bethke KP, Donnelly ED, Rudolph R, Pederson A, Summer T, Lottich SC, Ross DL, Laronga C, Loftus L, Abbott AM, Kelemen P, Hermanto U, Friedman NB, Bedi GC, Joh JE, Thompson WA, Hoefer RA, Wilson JP, Kang SK, Rosen B, Ruffer J, Bravo L, Police A, Escallon JM, Fyles AW, McCready DR, Graves GM, Rohatgi N, Eaker JA, Graves J, Willey SC, Tousimis EA, Collins BT, Shaw CM, Riley L, Deb N, Kelly T, Andolino DL, Boisvert ME, Lyons J, Small W, Grobmyer SR. TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer. Ann Surg Oncol. 2016 Sep.23(9):2809-2815. Pubmedid: 27160524.
  • Wells KJ, Pan TM, Vázquez-Otero C, Ung D, Ustjanauskas AE, Muñoz D, Laronga C, Roetzheim RG, Goldenstein M, Carrizosa C, Nuhaily S, Johnson K, Norton M, Sims E, Quinn GP. Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study. Support Care Cancer. 2016 Oct.24(10):4123-4130. Pubmedid: 27146492. Pmcid: PMC4995114.
  • Dossett LA, Lowe J, Sun W, Lee MC, Smith PD, Jacobsen PB, Laronga C. Prospective evaluation of skin and nipple-areola sensation and patient satisfaction after nipple-sparing mastectomy. J Surg Oncol. 2016 Jul.114(1):11-16. Pubmedid: 27087574. Pmcid: PMC7771573.
  • McGinty HL, Small BJ, Laronga C, Jacobsen PB. Predictors and patterns of fear of cancer recurrence in breast cancer survivors. Health Psychol. 2016 Jan.35(1):1-9. Pubmedid: 26030308.
  • Lee MC, Gonzalez SJ, Lin H, Zhao X, Kiluk JV, Laronga C, Mooney B. Prospective trial of breast MRI versus 2D and 3D ultrasound for evaluation of response to neoadjuvant chemotherapy. Ann Surg Oncol. 2015 Sep.22(9):2888-2894. Pubmedid: 25589151.
  • Applebaum MA, Miller BT, Lopez J, Doren EL, Laronga C, Smith PD. Change in Body Mass Index After Breast Reconstruction and Associated Complications. Eplasty. 2015 Sep.15:e43. Pubmedid: 26464749. Pmcid: PMC4591699.
  • Snow R, Reyna C, Johns C, Lee MC, Sun W, Fulp WJ, Kiluk JV, Laronga C. Outcomes with and without axillary node dissection for node-positive lumpectomy and mastectomy patients. Am J Surg. 2015 Oct.210(4):685-693. Pubmedid: 26210706.
  • Abbott AM, Dossett LA, Loftus L, Sun W, Fulp W, Sokol GH, Laronga C. Intraoperative radiotherapy for early breast cancer and age: clinical characteristics and outcomes. Am J Surg. 2015 Oct.210(4):624-628. Pubmedid: 26238075.
  • Acs G, Khakpour N, Kiluk J, Lee MC, Laronga C. The presence of extensive retraction clefts in invasive breast carcinomas correlates with lymphatic invasion and nodal metastasis and predicts poor outcome: a prospective validation study of 2742 consecutive cases. Am J Surg Pathol. 2015 Mar.39(3):325-337. Pubmedid: 25353283.
  • Quinn GP, Block RG, Clayman ML, Kelvin J, Arvey SR, Lee JH, Reinecke J, Sehovic I, Jacobsen PB, Reed D, Gonzalez L, Vadaparampil ST, Laronga C, Lee MC, Pow-Sang J, Eggly S, Franklin A, Shah B, Fulp WJ, Hayes-Lattin B. If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients' medical records. J Oncol Pract. 2015 Mar.11(2):137-144. Pubmedid: 25549654. Pmcid: PMC4799849.
  • Frazier TG, Fox KR, Smith JS, Laronga C, McSwain A, Paul D, Schultz M, Stilwill J, Teal C, Weisberg T, Vacchino JF, Sing AP, Cherepanov D, Hsiao W, Chang E, Broder MS. A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer. Pharmaceuticals (Basel). 2015 Mar.8(1):107-122. Pubmedid: 25789420. Pmcid: PMC4381203.
  • Jacobsen PB, Lee JH, Fulp W, Siegel EM, Shibata D, Laronga C, Gray J, Tanvetyanon T, Schreiber F, Brown R, Levine R, Cartwright T, Abesada-Terk G, Kim G, Alemany C, Faig D, Sharp P, Markham MJ, Malafa M. Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year Interval. J Oncol Pract. 2015 Jun.11(1):e103-e109. Pubmedid: 25352389. Pmcid: PMC4582141.
  • Weinfurtner RJ, Patel B, Laronga C, Lee MC, Falcon SL, Mooney BP, Yue B, Drukteinis JS. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics. Clin Breast Cancer. 2015 Jun.15(3):234-239. Pubmedid: 25579460.
  • Reyna C, Kiluk JV, Frelick A, Khakpour N, Laronga C, Lee MC. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS). J Surg Oncol. 2015 Jun.111(7):813-818. Pubmedid: 25753101.
  • Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, Garber JE, Gemignani ML, Gradishar WJ, Jordan JA, Korde LA, Kounalakis N, Krontiras H, Kumar S, Kurian A, Laronga C, Layman RM, Loftus LS, Mahoney MC, Merajver SD, Meszoely IM, Mortimer J, Newman L, Pritchard E, Pruthi S, Seewaldt V, Specht MC, Visvanathan K, Wallace A, Bergman MA, Kumar R. Breast Cancer Risk Reduction, Version 2.2015. J Natl Compr Canc Ne. 2015 Jul.13(7):880-915. Pubmedid: 26150582.
  • Agostinho JL, Zhao X, Sun W, Laronga C, Kiluk JV, Chen DT, Lee MC. Prediction of positive margins following breast conserving surgery. Breast. 2015 Feb.24(1):46-50. Pubmedid: 25466503.
  • Roetzheim RG, Lee JH, Fulp W, Matos Gomez E, Clayton E, Tollin S, Khakpour N, Laronga C, Lee MC, Kiluk JV. Acceptance and adherence to chemoprevention among women at increased risk of breast cancer. Breast. 2015 Feb.24(1):51-56. Pubmedid: 25491191. Pmcid: PMC4503358.
  • Laronga C, Gray JE, Siegel EM, Lee JH, Fulp WJ, Fletcher M, Schreiber F, Brown R, Levine R, Cartwright T, Abesada-Terk G, Kim G, Alemany C, Faig D, Sharp P, Markham MJ, Shibata D, Malafa M, Jacobsen PB. Florida Initiative for Quality Cancer Care: improvements in breast cancer quality indicators during a 3-year interval. J Am Coll Surg. 2014 Oct.219(4):638-45.e1. Pubmedid: 25086813. Pmcid: PMC4505727.
  • Reyna C, Lee MC, Frelick A, Khakpour N, Laronga C, Kiluk JV. Axillary burden of disease following false-negative preoperative axillary evaluation. Am J Surg. 2014 Oct.208(4):577-581. Pubmedid: 25118162.
  • Adams MC, Falcon S, Mooney BP, Laronga C, Chau A, Drukteinis JS. Short-term imaging follow-up of patients with concordant benign breast core needle biopsies: is it really worth it?. Diagn Interv Radiol. 2014 Nov.20(6):464-469. Pubmedid: 25205024. Pmcid: PMC4463290.
  • Doren EL, Van Eldik Kuykendall L, Lopez JJ, Laronga C, Smith PD. Free nipple grafting: an alternative for patients ineligible for nipple-sparing mastectomy?. Ann Plast Surg. 2014 Jun.72(6):S112-S115. Pubmedid: 24374396.
  • Kiluk JV, Prowler V, Lee MC, Khakpour N, Laronga C, Cox CE. Contralateral axillary nodal involvement from invasive breast cancer. Breast. 2014 Jun.23(3):291-294. Pubmedid: 24709584.
  • Goble RN, Drukteinis JS, Lee MC, Khakpour N, Kiluk JV, Laronga C. Early experience with ultrasound features after intrabeam intraoperative radiation for early stage breast cancer. J Surg Oncol. 2014 Jun.109(8):751-755. Pubmedid: 24862923.
  • Laronga C, Smith P. Nipple-sparing mastectomy: an oncologic and cosmetic perspective. Surg Oncol Clin N Am. 2014 Jul.23(3):549-566. Pubmedid: 24882350.
  • Loftus L, Laronga C, Coyne K, Hildreth L. Race of the clock: reducing delay to curative breast cancer surgery. J Natl Compr Canc Ne. 2014 Feb.12 Suppl 1:S13-S15. Pubmedid: 24614044.
  • Prowler VL, Joh JE, Acs G, Kiluk JV, Laronga C, Khakpour N, Lee MC. Surgical excision of pure flat epithelial atypia identified on core needle breast biopsy. Breast. 2014 Aug.23(4):352-356. Pubmedid: 24518220.
  • Lee MC, Laronga C. The pregnant breast cancer patient: are we failing our most vulnerable population?. Ann Surg Oncol. 2014 Aug.21(8):2474-2475. Pubmedid: 24743913.
  • Williams M, Eatrides J, Kim J, Talwar H, Esposito N, Szabunio M, Ismail-Khan R, Kiluk J, Lee M, Laronga C, Khakpour N. Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy. Am J Surg. 2013 Oct.206(4):567-573. Pubmedid: 23809673.
  • Acs G, Kiluk J, Loftus L, Laronga C. Comparison of Oncotype DX and Mammostrat risk estimations and correlations with histologic tumor features in low-grade, estrogen receptor-positive invasive breast carcinomas. Mod Pathol. 2013 Nov.26(11):1451-1460. Pubmedid: 23743933.
  • Doren EL, Parikh RP, Laronga C, Hiro ME, Sun W, Lee MC, Smith PD, Fulp WJ. Sequelae of fat grafting postmastectomy: an algorithm for management of fat necrosis. Eplasty. 2013 Jan.12:e53. Pubmedid: 23308300. Pmcid: PMC3516285.
  • Joh JE, Esposito NN, Kiluk JV, Laronga C, Khakpour N, Soliman H, Catherine Lee M. Pathologic tumor response of invasive lobular carcinoma to neo-adjuvant chemotherapy. Breast J. 2013 Apr.18(6):569-574. Pubmedid: 23034096.
  • Walsh N, Kiluk JV, Sun W, Khakpour N, Laronga C, Lee MC. Ipsilateral nodal recurrence after axillary dissection for breast cancer. J Surg Res. 2012 Sep.177(1):81-86. Pubmedid: 22498028.
  • Parikh RP, Doren EL, Mooney B, Sun WV, Laronga C, Smith PD. Differentiating fat necrosis from recurrent malignancy in fat-grafted breasts: an imaging classification system to guide management. Plast Reconstr Surg. 2012 Oct.130(4):761-772. Pubmedid: 23018689.
  • Laronga C. Going for the gold. Cancer Control. 2012 Oct.19(4):252-253. Pubmedid: 23037492.
  • Laronga C, Lewis JD, Smith PD. The changing face of mastectomy: an oncologic and cosmetic perspective. Cancer Control. 2012 Oct.19(4):286-294. Pubmedid: 23037496.
  • Deneve JL, Hoefer RA, Harris EE, Laronga C. Accelerated partial breast irradiation: a review and description of an early North American surgical experience with the intrabeam delivery system. Cancer Control. 2012 Oct.19(4):295-308. Pubmedid: 23037497.
  • Joh JE, Esposito NN, Kiluk JV, Laronga C, Lee MC, Loftus L, Soliman H, Boughey JC, Reynolds C, Lawton TJ, Acs PI, Gordan L, Acs G. The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists. Oncologist. 2012 Jun.16(11):1520-1526. Pubmedid: 22016474. Pmcid: PMC3233285.
  • Lee MC, Plews R, Rawal B, Kiluk JV, Loftus L, Laronga C. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review. Ann Surg Oncol. 2012 Jun.19(6):1818-1824. Pubmedid: 22203185.
  • Laronga C, Harness JK, Dixon M, Borgen PI. The role of the breast cancer surgeon in personalized cancer care: clinical utility of the 21-gene assay. Am J Surg. 2012 Jun.203(6):751-758. Pubmedid: 22516676.
  • Kumar NB, Vadaparampil ST, Mahajan N, Lilienfeld HS, Lee JH, Laronga C, Hakam A, Hein JJ, Egan KM, Arun B, Pal T. Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers. Hereditary Genet. 2012 Jun.1(2). Pubmedid: 26097796. Pmcid: PMC4474476.
  • Turaga KK, Chau A, Eatrides JM, Kiluk JV, Khakpour N, Laronga C, Lee MC. Selective application of routine preoperative axillary ultrasonography reduces costs for invasive breast cancers. Oncologist. 2012 Jan.16(7):942-948. Pubmedid: 21572122. Pmcid: PMC3228129.
  • Kiluk JV, Lee MC, Park CK, Meade T, Minton S, Harris E, Kim J, Laronga C. Male breast cancer: management and follow-up recommendations. Breast J. 2012 Feb.17(5):503-509. Pubmedid: 21883641.
  • Acs G, Paragh G, Rakosy Z, Laronga C, Zhang PJ. The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma. Mod Pathol. 2012 Feb.25(2):163-177. Pubmedid: 22020194.
  • Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ. Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ. Cancer. 2012 Dec.118(24):6022-6030. Pubmedid: 22674478. Pmcid: PMC3496800.
  • Joh JE, Han G, Kiluk JV, Laronga C, Khakpour N, Lee MC. Indications for axillary ultrasound use in breast cancer patients. Clin Breast Cancer. 2012 Dec.12(6):433-437. Pubmedid: 23062709.
  • Goedendorp MM, Andrykowski MA, Donovan KA, Jim HS, Phillips KM, Small BJ, Laronga C, Jacobsen PB. Prolonged impact of chemotherapy on fatigue in breast cancer survivors: a longitudinal comparison with radiotherapy-treated breast cancer survivors and noncancer controls. Cancer. 2012 Aug.118(15):3833-3841. Pubmedid: 22086766. Pmcid: PMC4007757.
  • Phillips KM, Jim HS, Small BJ, Laronga C, Andrykowski MA, Jacobsen PB. Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls. Cancer. 2012 Apr.118(7):1925-1932. Pubmedid: 22161750. Pmcid: PMC3305821.
  • Acs G, Esposito NN, Kiluk J, Loftus L, Laronga C. A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas. Mod Pathol. 2012 Apr.25(4):556-566. Pubmedid: 22173289.
  • Bardhan P, Bui MM, Minton S, Loftus L, Carter WB, Laronga C, Ismail-Khan R. HER2-positive male breast cancer with thyroid cancer: an institutional report and review of literature. Ann Clin Lab Sci. 2012.42(2):135-139. Pubmedid: 22585608.
  • Pimiento JM, Lee MC, Esposito NN, Kiluk JV, Khakpour N, Carter WB, Han G, Laronga C. Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion. J Oncol Pract. 2011 Sep.7(5):309-313. Pubmedid: 22211128. Pmcid: PMC3170064.
  • Pimiento JM, Gadgil PV, Santillan AA, Lee MC, Esposito NN, Kiluk JV, Khakpour N, Hartley TL, Yeh IT, Laronga C. Phyllodes tumors: race-related differences. J Am Coll Surg. 2011 Oct.213(4):537-542. Pubmedid: 21856184.
  • Drake RR, Cazares LH, Jones EE, Fuller TW, Semmes OJ, Laronga C. Challenges to developing proteomic-based breast cancer diagnostics. OMICS. 2011 May.15(5):251-259. Pubmedid: 21332380. Pmcid: PMC3128487.
  • Suber J, Malafa M, Smith P, Laronga C. Prosthetic breast reconstruction after implant-sparing mastectomy in patients with submuscular implants. Ann Plast Surg. 2011 May.66(5):546-550. Pubmedid: 21451381.
  • Gray JE, Laronga C, Siegel EM, Lee JH, Fulp WJ, Fletcher M, Schreiber F, Brown R, Levine R, Cartwright T, Abesada-Terk G, Kim G, Alemany C, Faig D, Sharp P, Markham MJ, Shibata D, Malafa M, Jacobsen PB. Degree of variability in performance on breast cancer quality indicators: findings from the Florida initiative for quality cancer care. J Oncol Pract. 2011 Jul.7(4):247-251. Pubmedid: 22043190. Pmcid: PMC3140448.
  • Lee MC, Eatrides J, Chau A, Han G, Kiluk JV, Khakpour N, Cox CE, Carter WB, Laronga C. Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers. Ann Surg Oncol. 2011 Jan.18(1):72-77. Pubmedid: 20585876.
  • Kiluk JV, Khakpour N, Lee MC, Lowe J, Harris E, Szabunio M, Laronga C. Management of abnormal Rotter's lymph nodes identified on preoperative breast magnetic resonance imaging. Am Surg. 2011 Jan.77(1):E10-E12. Pubmedid: 21396292.
  • Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, Macdonald DJ, Mahoney MC, Merajver SD, Meszoely I, Newman L, Pritchard E, Seewaldt V, Sellin RV, Shapiro CL, Ward JH. Breast cancer risk reduction. J Natl Compr Canc Ne. 2010 Oct.8(10):1112-1146. Pubmedid: 20971838.
  • Acs G, Esposito NN, Rakosy Z, Laronga C, Zhang PJ. Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma. Am J Surg Pathol. 2010 Nov.34(11):1637-1646. Pubmedid: 20975342.
  • Sarnaik AA, Meade T, King J, Acs G, Hoover S, Cox CE, Carter WB, Laronga C. Adenoid cystic carcinoma of the breast: a review of a single institution's experience. Breast J. 2010 May.16(2):208-210. Pubmedid: 20030648.
  • Rollison DE, Giuliano AR, Risendal BC, Sweeney C, Boulware D, Laronga C, Baumgartner KB, Byers T, Slattery ML. Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest. Breast Cancer Res Treat. 2010 Jun.121(3):661-669. Pubmedid: 19888649. Pmcid: PMC9278514.
  • Laronga C. The "molecular" buzz in breast cancer. Cancer Control. 2010 Jul.17(3):140-141. Pubmedid: 20664510.
  • Turaga K, Acs G, Laronga C. Gene expression profiling in breast cancer. Cancer Control. 2010 Jul.17(3):177-182. Pubmedid: 20664515.
  • Andrykowski MA, Donovan KA, Laronga C, Jacobsen PB. Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer. 2010 Dec.116(24):5740-5748. Pubmedid: 20734399. Pmcid: PMC4048855.
  • Loftus LS, Laronga C. Evaluating patients with chronic pain after breast cancer surgery: the search for relief. Jama. 2009 Nov.302(18):2034-2035. Pubmedid: 19903928.
  • Vadaparampil ST, Quinn GP, Miree CA, Brzosowicz J, Carter B, Laronga C. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients. Ann Surg Oncol. 2009 Jul.16(7):1973-1981. Pubmedid: 19408048.
  • Wagoner M, Laronga C, Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol. 2009 Jan.131(1):112-121. Pubmedid: 19095574.
  • Acs G, Paragh G, Chuang S, Laronga C, Zhang P. The presence of micropapillary features and retraction artifact in core needle biopsy material predicts lymph node metastasis in breast carcinoma. Am J Surg Pathol. 2009 Feb.33(2):202-210. Pubmedid: 18987549.
  • Laronga C, Lee MC, McGuire KP, Meade T, Carter WB, Hoover S, Cox CE. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg. 2009 Dec.209(6):746-752. Pubmedid: 19959044.
  • Rollison DE, Giuliano AR, Sellers TA, Laronga C, Sweeney C, Risendal B, Baumgartner KB, Byers T, Slattery ML. Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol. 2008 Feb.167(4):447-456. Pubmedid: 18033764. Pmcid: PMC2925515.
  • Kiluk J, Santillan A, Kaur P, Laronga C, Meade T, Ramos D, Cox C. Feasibility of sentinel lymph node biopsy through an inframammary incision for a nipple-sparing mastectomy. Ann Surg Oncol. 2008 Dec.15(12):3402-3406. Pubmedid: 18820974.
  • Laronga C, Drake RR. Proteomic approach to breast cancer. Cancer Control. 2007 Oct.14(4):360-368. Pubmedid: 17914336.
  • Shin S, Cazares L, Schneider H, Mitchell S, Laronga C, Semmes OJ, Perry RR, Drake RR. Serum biomarkers to differentiate benign and malignant mammographic lesions. J Am Coll Surg. 2007 May.204(5):1065-1071. Pubmedid: 17481542.
  • Shin S, Fournier K, Cole F, Laronga C. Effects of sentinel lymph node biopsy on surgical residency training. Am Surg. 2006 Sep.72(9):791-795. Pubmedid: 16986388.
  • Laronga C, Hasson D, Hoover S, Cox J, Cantor A, Cox C, Carter W. Paget's disease in the era of sentinel lymph node biopsy. Am J Surg. 2006 Oct.192(4):481-483. Pubmedid: 16978954.
  • Laronga C. Quality of life with skin-sparing mastectomy: sensation in the nipple-areola complex. J Support Oncol. 2006 May.4(5):234-235. Pubmedid: 16724646.
  • Maloney N, Koch M, Erb D, Schneider H, Goffman T, Elkins D, Laronga C. Impact of race on breast cancer in lower socioeconomic status women. Breast J. 2006 Jan.12(1):58-62. Pubmedid: 16409588.
  • Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 2004 Sep.10(5):405-411. Pubmedid: 15327493.
  • Becker S, Cazares LH, Watson P, Lynch H, Semmes OJ, Drake RR, Laronga C. Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. Ann Surg Oncol. 2004 Oct.11(10):907-914. Pubmedid: 15383419.
  • Pusztai L, Gregory BW, Baggerly KA, Peng B, Koomen J, Kuerer HM, Esteva FJ, Symmans WF, Wagner P, Hortobagyi GN, Laronga C, Semmes OJ, Wright GL, Drake RR, Vlahou A. Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer. 2004 May.100(9):1814-1822. Pubmedid: 15112261.
  • Fournier K, Schiller A, Perry RR, Laronga C. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg. 2004 Jun.239(6):859-863. Pubmedid: 15166965. Pmcid: PMC1356294.
  • Hughes M, Goffman TG, Perry RR, Laronga C. Obesity and lymphatic mapping with sentinel lymph node biopsy in breast cancer. Am J Surg. 2004 Jan.187(1):52-57. Pubmedid: 14706586.
  • Laronga C, Becker S, Watson P, Gregory B, Cazares L, Lynch H, Perry RR, Wright GL, Drake RR, Semmes OJ. SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. Dis Markers. 2004 Aug.19(4-5):229-238. Pubmedid: 15258337. Pmcid: PMC3851103.
  • Goffman TE, Miller M, Laronga C, Oliver S, Wong P. Shielding of the contralateral breast during tangential irradiation. Am J Clin Oncol. 2004 Aug.27(4):436-439. Pubmedid: 15289741.
  • Vlahou A, Laronga C, Wilson L, Gregory B, Fournier K, McGaughey D, Perry RR, Wright GL, Semmes OJ. A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer. 2003 Aug.4(3):203-209. Pubmedid: 14499014.
  • Laronga C, Kiluk J. Commentary on "Improving surgical outcomes: standardizing the reporting of incidence and severity of acute lymphedema after sentinel lymph node biopsy and axillary node dissection". In: Breast Diseases: a Year Book Quarterly. 2007 ed. St Louis, MO: Mosby Yearbook; 2007;170-171.
  • Kiluk J, Laronga C. Commentary on "The Clinical Value of Parasternal Sentinel Lymph Node Biopsy in Breast Cancer".. In: Breast Diseases: a Year Book Quarterly. 2007 ed. St Louis, MO: Mosby Yearbook; 2007;382-383.

Patient Comments
Overall Satisfaction

146 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments